Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ.

News

Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ.

By Reuters Staff

NEW YORK (Reuters Health) - Obinutuzumab combined with bendamustine is more effective than bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma, according to results from the phase 3 GADOLIN trial.

Read More

Research in Review

The ability of chimeric antigen receptor (CAR) T-cells to perform multiple functions is associated with improved outcomes for patients with advanced non-Hodgkin lymphoma, offering a biomarker for response, according to a retrospective analysis presented at the 2017 American Association for Cancer Research Annual Meeting (April 1-5; abstract 2990).
-----

Read More

Subscribe to Non-Hodgkin Lymphoma